ZimVie Inc. (NASDAQ:ZIMV) Shares Sold by Jane Street Group LLC

Jane Street Group LLC lessened its stake in shares of ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 60.1% in the 4th quarter, according to its most recent disclosure with the SEC. The firm owned 18,881 shares of the company's stock after selling 28,460 shares during the period. Jane Street Group LLC owned 0.07% of ZimVie worth $263,000 as of its most recent SEC filing.

Several other hedge funds have also bought and sold shares of ZIMV. SG Americas Securities LLC boosted its stake in shares of ZimVie by 15.7% in the fourth quarter. SG Americas Securities LLC now owns 11,110 shares of the company's stock worth $155,000 after acquiring an additional 1,508 shares during the period. Wells Fargo & Company MN boosted its stake in shares of ZimVie by 17.8% in the fourth quarter. Wells Fargo & Company MN now owns 17,037 shares of the company's stock worth $238,000 after acquiring an additional 2,569 shares during the period. Integrated Quantitative Investments LLC bought a new position in shares of ZimVie in the fourth quarter worth about $248,000. Principal Financial Group Inc. boosted its stake in shares of ZimVie by 9.8% in the fourth quarter. Principal Financial Group Inc. now owns 19,054 shares of the company's stock worth $266,000 after acquiring an additional 1,702 shares during the period. Finally, Bailard Inc. boosted its stake in shares of ZimVie by 35.0% in the fourth quarter. Bailard Inc. now owns 21,194 shares of the company's stock worth $296,000 after acquiring an additional 5,494 shares during the period. Institutional investors own 95.63% of the company's stock.

ZimVie Stock Down 0.5%

NASDAQ ZIMV traded down $0.05 during midday trading on Thursday, hitting $9.12. 97,591 shares of the company traded hands, compared to its average volume of 211,306. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. The company has a market cap of $253.96 million, a PE ratio of -0.70 and a beta of 2.10. ZimVie Inc. has a 52 week low of $8.15 and a 52 week high of $22.40. The company's 50-day simple moving average is $9.17 and its 200-day simple moving average is $12.00.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its quarterly earnings data on Thursday, May 8th. The company reported $0.27 earnings per share for the quarter, topping analysts' consensus estimates of $0.21 by $0.06. The firm had revenue of $112.00 million during the quarter, compared to analysts' expectations of $113.10 million. ZimVie had a positive return on equity of 2.90% and a negative net margin of 77.31%. As a group, equities research analysts forecast that ZimVie Inc. will post 0.6 earnings per share for the current year.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently commented on ZIMV shares. UBS Group decreased their target price on ZimVie from $16.00 to $10.00 and set a "neutral" rating on the stock in a research report on Thursday, May 15th. B. Riley began coverage on ZimVie in a report on Thursday, April 10th. They issued a "buy" rating and a $16.00 target price for the company. Finally, Needham & Company LLC reaffirmed a "hold" rating on shares of ZimVie in a research note on Wednesday, April 9th.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.